Evidence map›Paper›PMID 41204642›Full record

ReviewFEBS letters2026

By dawn or dusk-how circadian timing rewrites bacterial infection outcomes.

Devons Mo, Catherine S Palmer, Jacqueline M Kimmey

Abstract readReview
In one paragraph

Review in FEBS letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Devons MoDepartment of Microbiology and Environmental Toxicology, University of California, Santa Cruz, CA, USA.
Catherine S PalmerDepartment of Microbiology and Environmental Toxicology, University of California, Santa Cruz, CA, USA.
Jacqueline M KimmeyDepartment of Microbiology and Environmental Toxicology, University of California, Santa Cruz, CA, USA.ORCID 0000-0003-1330-8525

Funding

Microbial regulation of vertebrate circadian clocksR35GM147509 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI Jacqueline Misum Kimmey · 2022 to 2026
$1.9M
Alfred P. Sloan FoundationNIGMS NIH HHS R35 GM147509NIGMS NIH HHS R35GM147509Pew Charitable Trusts
6 · The paper itself

Abstract

The immune system exists in perpetual co-evolution with pathogens, and microbial pathogenesis is inexorably linked to the cyclical interactions between the pathogen and the host. Because pathogens exploit the immune system in unique ways, the antimicrobial efficacy of any given immune process varies between pathogens, and the consequences of activation or inhibition of antimicrobial programs must be interpreted in the context of the given pathogen. An increasing body of literature shows that numerous facets of the immune system are tightly regulated by the circadian clock, with multiple immune processes demonstrating increased activity during certain times of the day. However, the field of circadian immunology has generally given its attention to unraveling the mechanism of circadian regulation and comparatively little attention to how these circadian oscillations may influence the ultimate outcome of diseases. Therefore, this review aims to interpret these findings in the context of a select number of clinically relevant pathogens: Salmonella enterica, Listeria monocytogenes, and Streptococcus pneumoniae. In this way, we hope to discuss the complex factors that determine how the circadian clock regulates disease progression.

Indexed as

Bacterial InfectionsCircadian ClocksCircadian RhythmAnimalsHost-Pathogen InteractionsHumansListeria monocytogenesSalmonella entericaStreptococcus pneumoniaebacteriacircadianclockimmunityinfectionListeria monocytogenesmicrobepathogenesisSalmonella entericaStreptococcus pneumoniae

Identifiers

PMID41204642
PMCPMC13022752

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.